| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 10 | +70.00% | -1.31% | +0.84% | -2.15% | -4.86% | — |
| 14d | 10 | +50.00% | -3.50% | +0.35% | -3.85% | -5.41% | — |
| 30d | 10 | +70.00% | -5.16% | +1.55% | -6.71% | -12.12% | — |
| 60d | 10 | +50.00% | +9.07% | +2.60% | +6.46% | -2.44% | — |
| 90d | 10 | +50.00% | +13.04% | +3.59% | +9.45% | -13.17% | — |
| 180d | 10(1 pending) | +44.44% | +62.99% | +10.08% | +52.91% | +5.26% | — |
| 1y | 10(4 pending) | +0.00% | +89.12% | +19.77% | +69.34% | +56.93% | — |
| 2y | 10(10 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,773 | $3.16 | $34.0K | 702,829 | Jun 17, 2026 | Jun 18, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 6,424 | $2.71 | $17.4K | 713,602 | Mar 17, 2026 | Mar 18, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 247,430 | — | — | 720,026 | Mar 13, 2026 | Mar 16, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 221,270 | — | — | 221,270 | Mar 13, 2026 | Mar 16, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,337 | $3.67 | $26.9K | 467,525 | Dec 17, 2025 | Dec 18, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,046 | $2.81 | $19.8K | 474,862 | Sep 17, 2025 | Sep 18, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 11 | $1.12 | $12 | 474,462 | Jul 17, 2025 | Jul 18, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,229 | $1.15 | $8.3K | 474,473 | Jun 17, 2025 | Jun 18, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 8 | $0.96 | $8 | 481,702 | Apr 17, 2025 | Apr 21, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,535 | $1.48 | $5.2K | 481,710 | Mar 18, 2025 | Mar 19, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 238,000 | — | — | 485,245 | Mar 14, 2025 | Mar 17, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 213,000 | — | — | 213,000 | Mar 14, 2025 | Mar 17, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 11 | $1.86 | $20 | 240,671 | Feb 19, 2025 | Feb 20, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 9 | $2.27 | $20 | 240,682 | Jan 17, 2025 | Jan 21, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Financial Officer | 3,245 | $2.42 | $7.9K | 240,691 | Dec 17, 2024 | Dec 18, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Mar 14, 2024 | Mar 15, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 170,000 | — | — | 243,936 | Mar 14, 2024 | Mar 15, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 39,000 | — | — | 39,000 | Mar 14, 2023 | Mar 15, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,200 | — | — | 73,936 | Mar 14, 2023 | Mar 15, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 66,000 | — | — | 66,000 | Dec 9, 2022 | Dec 12, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 44,000 | — | — | 63,771 | Dec 9, 2022 | Dec 12, 2022 ↗ | View → |